ZA200305576B - Peptides having affinity for the GP120 viral protein and use thereof. - Google Patents

Peptides having affinity for the GP120 viral protein and use thereof. Download PDF

Info

Publication number
ZA200305576B
ZA200305576B ZA200305576A ZA200305576A ZA200305576B ZA 200305576 B ZA200305576 B ZA 200305576B ZA 200305576 A ZA200305576 A ZA 200305576A ZA 200305576 A ZA200305576 A ZA 200305576A ZA 200305576 B ZA200305576 B ZA 200305576B
Authority
ZA
South Africa
Prior art keywords
xaa
peptide
gpl20
viral
sequence
Prior art date
Application number
ZA200305576A
Other languages
English (en)
Inventor
Claudio Vita
Loic Martin
Christian Roumestand
Francisco Veas
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Publication of ZA200305576B publication Critical patent/ZA200305576B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200305576A 2001-01-23 2003-07-18 Peptides having affinity for the GP120 viral protein and use thereof. ZA200305576B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0100893A FR2819809B1 (fr) 2001-01-23 2001-01-23 Peptides presentant un affinite pour la proteine virale gp120, et utilisation de ces peptides

Publications (1)

Publication Number Publication Date
ZA200305576B true ZA200305576B (en) 2004-07-21

Family

ID=8859145

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200305576A ZA200305576B (en) 2001-01-23 2003-07-18 Peptides having affinity for the GP120 viral protein and use thereof.

Country Status (16)

Country Link
US (1) US7374875B2 (de)
EP (1) EP1368372B1 (de)
JP (1) JP4307838B2 (de)
KR (1) KR100910199B1 (de)
CN (1) CN1304421C (de)
AT (1) ATE370160T1 (de)
AU (1) AU2002233424B2 (de)
CA (1) CA2435097A1 (de)
DE (1) DE60221805T2 (de)
DK (1) DK1368372T3 (de)
ES (1) ES2291439T3 (de)
FR (1) FR2819809B1 (de)
IL (2) IL156799A0 (de)
MX (1) MXPA03006263A (de)
WO (1) WO2002059146A2 (de)
ZA (1) ZA200305576B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076640A1 (en) * 1999-02-15 2004-04-22 Institut De Recherche Pour Le Developement (I.R.D) Vaccine compositions against infectious pathologies for mammals
FR2838649B1 (fr) * 2002-04-19 2006-01-13 Commissariat Energie Atomique Composition anti-vih, procede de fabrication et medicament
WO2007020886A1 (ja) 2005-08-16 2007-02-22 Sanyo Chemical Industries, Ltd. タンパク質のリフォールディング剤およびリフォールディング方法
JP4625433B2 (ja) * 2005-08-16 2011-02-02 三洋化成工業株式会社 タンパク質のリフォールディング剤およびリフォールディング方法
WO2007144685A1 (en) * 2006-06-13 2007-12-21 Commissariat A L'energie Atomique Cd4 mimic peptides and their uses
FR2904627B1 (fr) * 2006-08-04 2008-11-07 Pasteur Institut Nouveaux peptides actives, purifies et isoles, derives du recepteur cd4 (mini-cd4) et leur procece de preparation
JP2008209378A (ja) * 2007-01-31 2008-09-11 Fujifilm Corp バイオセンサー基板
EP2087911A1 (de) * 2008-02-06 2009-08-12 Institut Pasteur Konjugierte Moleküle mit einem Peptid aus dem mit einem Polyanion gekoppelten CD4-Rezeptor zur Behandlung von AIDS
CA2943228C (en) * 2014-03-20 2023-03-14 Bristol-Myers Squibb Company Stabilized fibronectin based scaffold molecules
US11174298B2 (en) * 2016-11-09 2021-11-16 James P. Tam Preparation and use of ginsentides and ginsentide-like peptides
CN108640977A (zh) * 2018-06-18 2018-10-12 上海大学 特异性结合HIV上包膜糖蛋白gp120的多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599324A (en) * 1984-11-21 1986-07-08 Smithkline Beckman Corporation V1-vasopressin antagonists
US4684622A (en) * 1984-11-21 1987-08-04 Smithkline Beckman Corporation Compositions and methods for producing vasodilation and antioxytocic activity
US4721704A (en) * 1986-05-09 1988-01-26 Peninsula Laboratories, Inc. Potent synthetic atrial peptide analogs

Also Published As

Publication number Publication date
MXPA03006263A (es) 2005-04-29
US7374875B2 (en) 2008-05-20
JP4307838B2 (ja) 2009-08-05
CN1487951A (zh) 2004-04-07
IL156799A0 (en) 2004-02-08
DE60221805T2 (de) 2008-05-15
CN1304421C (zh) 2007-03-14
CA2435097A1 (en) 2002-08-01
KR20040011454A (ko) 2004-02-05
FR2819809A1 (fr) 2002-07-26
DE60221805D1 (de) 2007-09-27
JP2004535366A (ja) 2004-11-25
KR100910199B1 (ko) 2009-07-30
WO2002059146A3 (fr) 2002-12-05
IL156799A (en) 2010-04-15
US20060121538A1 (en) 2006-06-08
EP1368372A2 (de) 2003-12-10
FR2819809B1 (fr) 2003-05-16
ES2291439T3 (es) 2008-03-01
AU2002233424B2 (en) 2006-01-05
EP1368372B1 (de) 2007-08-15
DK1368372T3 (da) 2008-01-07
ATE370160T1 (de) 2007-09-15
WO2002059146A2 (fr) 2002-08-01

Similar Documents

Publication Publication Date Title
JP4010560B2 (ja) Ｈｉｖ複製を阻害する化合物
TWI227242B (en) Peptide composition for prevention and treatment of HIV infection and immune disorders
US5840313A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
EP2035453B1 (de) Mimetische cd4-peptide und ihre verwendungen
US5589175A (en) Peptides for induction of neutralizing antibodies against human immunodeficiency virus
CZ200288A3 (cs) Hybridní polypeptid
JPH06340698A (ja) Ｈｉｖ−１ のインヒビターとしての合成ポリペプチド
CA2135278C (en) Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
US7374875B2 (en) Peptides having affinity for the gp120 viral protein and use thereof
US5346989A (en) Peptides for use in induction of T cell activation against HIV-1
CA2022523A1 (en) Chemically modified cd4 peptide fragments having anti-retroviral properties
AU662534B2 (en) Peptides for use in induction of T cell activation against HIV-1
EP0693938B1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
PT671947E (pt) Composicoes para produzir respostas de linfocitos t citotoxicas contra virus
JP2002338600A (ja) Ｈｉｖ−１の感染を抑制するポリペプチド
CA2452663A1 (en) Method for screening molecules which can bind to the gp120 protein of the immunodeficiency virus
Syennerholm et al. Vahlne et al.
JPH09504273A (ja) Ｈｉｖに対して使用するための多分岐ペプチド構築物